Summary
Johnson & Johnson (JNJ) announced the completion of a significant public offering of debt securities on February 20, 2025. The company successfully issued a total of $5.25 billion in notes across various maturities ranging from 2027 to 2035. This capital raise includes $750 million in 4.500% Notes due 2027, $750 million in 4.550% Notes due 2028, $1 billion in 4.700% Notes due 2030, $1.25 billion in 4.850% Notes due 2032, and $1.25 billion in 5.000% Notes due 2035. The offering was conducted under the company's existing shelf registration statement.
Key Highlights
- 1JNJ completed a $5.25 billion debt offering on February 20, 2025.
- 2The offering consisted of notes with maturities between 2027 and 2035.
- 3Interest rates on the notes range from 4.500% to 5.000% annually.
- 4The company issued specific tranches of $750M (2027 & 2028), $1B (2030), and $1.25B (2032 & 2035).
- 5This offering was executed under Johnson & Johnson's Form S-3 Registration Statement.
- 6The company entered into an underwriting agreement with major financial institutions including Citigroup, BofA Securities, and J.P. Morgan.